| 000 | 01906 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250515221421.0 | ||
| 264 | 0 | _c20100429 | |
| 008 | 201004s 0 0 eng d | ||
| 022 | _a1534-6080 | ||
| 024 | 7 |
_a10.1097/tp.0b013e3181cbe024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNavarro-Manchón, Josep | |
| 245 | 0 | 0 |
_aPredictors of renal dysfunction at 1 year in heart transplant patients. _h[electronic resource] |
| 260 |
_bTransplantation _cApr 2010 |
||
| 300 |
_a977-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xetiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlomerular Filtration Rate _xdrug effects |
| 650 | 0 | 4 |
_aHeart Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 |
_aKidney Diseases _xblood |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMartínez-Dolz, Luis | |
| 700 | 1 | _aAlmenar Bonet, Luis | |
| 700 | 1 | _aSánchez-Lázaro, Ignacio | |
| 700 | 1 | _aRaso Raso, Rafael | |
| 700 | 1 | _aGrima, Esther Zorio | |
| 700 | 1 | _aAgüero Ramon-Llin, Jaime | |
| 700 | 1 | _aBuendía Fuentes, Francisco | |
| 700 | 1 | _aSánchez-Gómez, Juan-Miguel | |
| 700 | 1 | _aSalvador Sanz, Antonio | |
| 773 | 0 |
_tTransplantation _gvol. 89 _gno. 8 _gp. 977-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/tp.0b013e3181cbe024 _zAvailable from publisher's website |
| 999 |
_c19763499 _d19763499 |
||